FDA Extends Comment Period For Its “Request for Quality Metrics” Draft Guidance

August 28, 2015

Last month, FDA published a draft guidance titled “Request for Quality Metrics,” which outlined the ways in which it intends to collect and use quality metrics. The guidance states that the data will be used for various activities, including: to predict potential drug shortages, improve the evaluation of drug manufacturing and control operations, improve the Agency’s efficiency and effectiveness of establishment inspections, and develop a schedule for risk-based inspections.

On Monday, August 27, 2015, FDA held a public meeting in which they discussed this draft guidance with drug makers and other industry personnel. This was the first opportunity for any open discussion between the industry and FDA, and as would be expected, there were many questions and a plethora of discussions that occurred. While the Agency was able to provide some clarification on some of the questions that were posed, it also announced that the final guidance would not be released until 2016. In addition, FDA has decided to extend the comment period for an additional 60 days, allowing feedback to be submitted until November 27, 2015.

Agency Alerts General Regulatory

August 15, 2016

FDA Seeks Nominations for Members to Serve on the Tobacco Products Scientific Advisory Committee

On Monday, August 15th, FDA issued a notice requesting nominations for a nonvoting member to serve on the Tobacco Products Scientific Advisory Committee to represent the interests of tobacco...

Read the Full Article
Agency Alerts

February 24, 2016

FDA Submissions for Interoperable Medical Devices – Comment Period Extended for Draft Guidance

Additional information on FDA’s recommendations for interoperable medical devices is available in our blog post entitled “A Closer Look at FDA’s Draft Guidance Regarding Premarket Submissions for...

Read the Full Article
Medical Devices Agency Alerts

February 28, 2019

Draft Guidance: Requesting Nonbinding Feedback After an FDA Inspection of Your Medical Device Establishment

On Tuesday, February 19th, FDA published a draft guidance for medical device makers which identifies a process for companies to request nonbinding feedback on certain FDA Form 483 deficiencies noted...

Read the Full Article